Literature DB >> 1577271

Transcriptional regulation of the HIV-1 promoter by NF-kappa B in vitro.

M Kretzschmar1, M Meisterernst, C Scheidereit, G Li, R G Roeder.   

Abstract

NF-kappa B, purified from HeLa cell cytosol, and a recombinant p50 subunit of NF-kappa B alone (expressed in and purified from bacteria) both stimulated transcription from the HIV-1 promoter in vitro (at least up to 15-fold). A deletion analysis of the p50 subunit revealed that transcriptional activation was mediated by the conserved c-rel-related domain. I kappa B-beta (or a related protein), which binds to the p65 but not the p50 subunit of NF-kappa B, inhibited stimulation by natural NF-kappa B but not by recombinant p50. Experiments employing a purified transcription system revealed that efficient induction of transcription by both natural NF-kappa B or recombinant p50 required a cofactor fraction in addition to the general initiation factors. Combined with DNA-binding experiments, these studies suggest a role of p50 homodimers in transcriptional activation of certain promoters, with a possible preference for those carrying symmetric NF-kappa B recognition sites, and a potential role of I kappa B-beta in direct transcriptional regulation within the nucleus.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1577271     DOI: 10.1101/gad.6.5.761

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  59 in total

1.  Nuclear factor-kappaB (NF-kappaB) regulates proliferation and branching in mouse mammary epithelium.

Authors:  D M Brantley; C L Chen; R S Muraoka; P B Bushdid; J L Bradberry; F Kittrell; D Medina; L M Matrisian; L D Kerr; F E Yull
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

Review 2.  Regulation of HIV-1 transcription.

Authors:  K A Roebuck; M Saifuddin
Journal:  Gene Expr       Date:  1999

3.  NF-κB gene signature predicts prostate cancer progression.

Authors:  Renjie Jin; Yajun Yi; Fiona E Yull; Timothy S Blackwell; Peter E Clark; Tatsuki Koyama; Joseph A Smith; Robert J Matusik
Journal:  Cancer Res       Date:  2014-03-31       Impact factor: 12.701

4.  Constitutive expression of Bc1-3 in thymocytes increases the DNA binding of NF-kappaB1 (p50) homodimers in vivo.

Authors:  J H Caamaño; P Perez; S A Lira; R Bravo
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

5.  Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor.

Authors:  A Ray; K E Prefontaine
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

6.  Coexpression of NF-kappa B/Rel and Sp1 transcription factors in human immunodeficiency virus 1-induced, dendritic cell-T-cell syncytia.

Authors:  A Granelli-Piperno; M Pope; K Inaba; R M Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

7.  Organ-specific roles for transcription factor NF-kappaB in reovirus-induced apoptosis and disease.

Authors:  Sean M O'Donnell; Mark W Hansberger; Jodi L Connolly; James D Chappell; Melissa J Watson; Janene M Pierce; J Denise Wetzel; Wei Han; Erik S Barton; J Craig Forrest; Tibor Valyi-Nagy; Fiona E Yull; Timothy S Blackwell; Jeffrey N Rottman; Barbara Sherry; Terence S Dermody
Journal:  J Clin Invest       Date:  2005-08-11       Impact factor: 14.808

8.  Evidence for differential functions of the p50 and p65 subunits of NF-kappa B with a cell adhesion model.

Authors:  R Narayanan; K A Higgins; J R Perez; T A Coleman; C A Rosen
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

9.  Role of cysteine62 in DNA recognition by the P50 subunit of NF-kappa B.

Authors:  J R Matthews; W Kaszubska; G Turcatti; T N Wells; R T Hay
Journal:  Nucleic Acids Res       Date:  1993-04-25       Impact factor: 16.971

10.  15-Deoxy-Delta12,14-prostaglandin J2 inhibits HIV-1 transactivating protein, Tat, through covalent modification.

Authors:  Parisa Kalantari; Vivek Narayan; Andrew J Henderson; K Sandeep Prabhu
Journal:  FASEB J       Date:  2009-03-19       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.